These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30863782)

  • 41. The profile of polyunsaturated fatty acids in juvenile idiopathic arthritis and association with disease activity.
    Gorczyca D; Postępski J; Czajkowska A; Paściak M; Prescha A; Olesińska E; Gruenpeter A; Lachór-Motyka I; Szponar B
    Clin Rheumatol; 2017 Jun; 36(6):1269-1279. PubMed ID: 28247163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand.
    Weivoda S; Andersen JD; Skogen A; Schlievert PM; Fontana D; Schacker T; Tuite P; Dubinsky JM; Jemmerson R
    J Immunol Methods; 2008 Jul; 336(1):22-9. PubMed ID: 18436231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by γ/δ T Cells in Systemic Juvenile Idiopathic Arthritis.
    Kessel C; Lippitz K; Weinhage T; Hinze C; Wittkowski H; Holzinger D; Fall N; Grom AA; Gruen N; Foell D
    Arthritis Rheumatol; 2017 Jul; 69(7):1480-1494. PubMed ID: 28296284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy.
    Martini G; Biscaro F; Boscaro E; Calabrese F; Lunardi F; Facco M; Agostini C; Zulian F; Fadini GP
    BMC Musculoskelet Disord; 2015 Apr; 16():103. PubMed ID: 25925313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles.
    Shimizu M; Nakagishi Y; Yachie A
    Cytokine; 2013 Feb; 61(2):345-8. PubMed ID: 23276493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Case of systemic-onset juvenile idiopathic arthritis complicated with sepsis --usefulness of cytokine profile for the differentiation between macrophage activation syndrome and sepsis.
    Yokoyama T; Shimizu M; Ikeno I; Hashida Y; Fujita S; Shimura S; Hatasaki K; Shintani N; Yachie A
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(2):105-11. PubMed ID: 21628853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Value of serum ferritin in measuring the activation and prognosis in systemic onset juvenile idiopathic arthritis].
    Zhou YF; Li CF; Wang J; Han TX; Kuang WY; Deng JH; Zhang JM; Tan XH
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2487-9. PubMed ID: 24300271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and associated inflammatory biomarker features predictive of short-term outcomes in non-systemic juvenile idiopathic arthritis.
    Rezaei E; Hogan D; Trost B; Kusalik AJ; Boire G; Cabral DA; Campillo S; Chédeville G; Chetaille AL; Dancey P; Duffy C; Watanabe Duffy K; Gordon J; Guzman J; Houghton K; Huber AM; Jurencak R; Lang B; Morishita K; Oen KG; Petty RE; Ramsey SE; Scuccimarri R; Spiegel L; Stringer E; Taylor-Gjevre RM; Tse SML; Tucker LB; Turvey SE; Tupper S; Yeung RSM; Benseler S; Ellsworth J; Guillet C; Karananayake C; Muhajarine N; Roth J; Schneider R; Rosenberg AM
    Rheumatology (Oxford); 2020 Sep; 59(9):2402-2411. PubMed ID: 31919503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis.
    Lotito AP; Campa A; Silva CA; Kiss MH; Mello SB
    J Rheumatol; 2007 Apr; 34(4):823-30. PubMed ID: 17343316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating survivin indicates severe course of juvenile idiopathic arthritis.
    Galeotti L; Adrian K; Berg S; Tarkowski A; Bokarewa M
    Clin Exp Rheumatol; 2008; 26(2):373-8. PubMed ID: 18565266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating levels of the adipokines vaspin and omentin in patients with juvenile idiopathic arthritis, and relation to disease activity.
    Cantarini L; Simonini G; Fioravanti A; Generoso M; Bacarelli MR; Dini E; Galeazzi M; Cimaz R
    Clin Exp Rheumatol; 2011; 29(6):1044-8. PubMed ID: 22032341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation of Complement-activating Pattern Recognition Molecules and Associated Enzymes as Possible Inflammatory Markers in Oligoarticular and Systemic Juvenile Idiopathic Arthritis.
    Petri C; Thiel S; Jensenius JC; Herlin T
    J Rheumatol; 2015 Jul; 42(7):1252-8. PubMed ID: 26034144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance of decreased serum concentration of cartilage oligomeric matrix protein in systemic juvenile idiopathic arthritis.
    Urakami T; Manki A; Inoue T; Oda M; Tanaka H; Morishima T
    J Rheumatol; 2006 May; 33(5):996-1000. PubMed ID: 16652429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Usefulness of serum leucine-rich alpha-2 glycoprotein as a disease activity biomarker in patients with rheumatoid arthritis.
    Ha YJ; Kang EJ; Lee SW; Lee SK; Park YB; Song JS; Choi ST
    J Korean Med Sci; 2014 Sep; 29(9):1199-204. PubMed ID: 25246736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Definitive differences in laboratory and radiological characteristics between two subtypes of juvenile idiopathic arthritis: systemic arthritis and polyarthritis.
    Ozawa R; Inaba Y; Mori M; Hara R; Kikuchi M; Higuchi R; Miyamae T; Imagawa T; Fujiwara T; Saito T; Yokota S
    Mod Rheumatol; 2012 Aug; 22(4):558-64. PubMed ID: 21984130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relation of interleukin-6, TNF-alpha and interleukin-1alpha with disease activity and severity in juvenile idiopathic arthritis patients.
    Spîrchez M; Samaşca G; Iancu M; Bolba C; Miu N
    Clin Lab; 2012; 58(3-4):253-60. PubMed ID: 22582498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages.
    Chen CY; Tsao CH; Ou LS; Yang MH; Kuo ML; Huang JL
    Ann Rheum Dis; 2002 Feb; 61(2):167-70. PubMed ID: 11796405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biomarker significance of interleukins, IL-37 and IL-38 in patients with juvenile idiopathic arthritis.
    Sharquie IK
    Med J Malaysia; 2022 Jul; 77(4):415-419. PubMed ID: 35902929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma miR-26a as a Diagnostic Biomarker Regulates Cytokine Expression in Systemic Juvenile Idiopathic Arthritis.
    Sun J; Feng M; Wu F; Ma X; Lu J; Kang M; Liu Z
    J Rheumatol; 2016 Aug; 43(8):1607-14. PubMed ID: 27252421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum protein signatures differentiate paediatric autoimmune/inflammatory disorders.
    Carlsson E; Midgley A; Perkins S; Caamano-Gutierrez E; Gritzfeld JF; Beresford MW; Hedrich CM
    Clin Immunol; 2021 Aug; 229():108790. PubMed ID: 34197952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.